Why the body matters in major depressive disorder: neuroimaging findings of somatic symptoms and ongoing challenges.
A framework is provided for understanding the neural substrates of somatic symptoms in MDD, developing somatic phenotype-based biomarkers and targeted neuromodulation therapies, and integrating systems-level neuroimaging into precision psychiatry to advance biologically informed diagnosis/treatment.